Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.’s Wishes

The peptides, which are increasingly marketed as providing longevity and health benefits, were removed in 2023 from the agency’s list of products that compounding pharmacies can sell.

Christina Jewett and Dani Blum
Author: Christina Jewett and Dani Blum

Written by

Christina Jewett and Dani Blum

in

Advertising and Marketing, Black Markets, Consumer Protection, Dietary Supplements and Herbal Remedies, Drugs (Pharmaceuticals), Food and Drug Administration, Health and Human Services Department, Kennedy, Robert F Jr, Longevity, Recalls and Bans of Products, Regulation and Deregulation of Industry, Trump, Donald J, United States
←Three charged with murder over death of girl, 16
New England Patriots And Seattle Seahawks Set For HBO’s ‘Hard Knocks’→

More posts

  • Protesters, leaders push back against DHS over Newark detention facility conditions

  • Goldman and Lander spar hard over Israel

  • Snowflake climbs after Q1 results top expectations, guidance gets a boost

  • Synopsys drops despite better than expected Q2 results, big boost to full-year guidance

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube